Agnieszka Sekula and Dr. Prash Puspanathan, co-founders of Enosis Therapeutics, an Australia-based medical technology and psychedelic research company, formed to advance experiential design in psychedelic-based treatment by leveraging virtual reality’s unique, state-altering properties, discuss the publishing of their first academic paper examining the synergistic applications of VR technology and psychedelic-assisted psychotherapy addressing new ways to explore how clinicians and researchers are thinking about therapeutic environments and overcoming barriers that may obstruct existing psychedelic protocols.
Agnieszka Sekula has used cutting edge biotech tools, including customized imaging robots, 3D modelling and VR, to innovate medical research all over the world, including forensic medicine in Switzerland, space medicine in Austria and translational science in Singapore. She is currently a PhD candidate at the Centre for Human Psychopharmacology at Swinburne University in Australia. Winner of the Best Speaker award at 3D MED Australia and the MiLabs Image of the Year award, among others. Agnieszka’s academic work was published in the Journal of Forensic Radiology and Imaging, and the Journal of Nuclear Medicine.